1.2.3 Bacterial cells The Company has a share capital of CHF 106,691,000, divided into 106,691,000 fully paid bearer shares with a nominal value of 1 Swiss franc each. (February 3, 2022). Roche Holding Ltd has no restrictions as to ownership of its shares or non-voting equity securities. 1.3 Market by Application Our anniversary year was no exception: In 2021 our more than 100,000 employees and our partners developed, manufactured and provided global access to state-of-the-art diagnostics and treatments for serious diseases, particularly for COVID-19. Get in touch with us. This text provides general information. c) 2021 dividend proposed by the Board of Directors. International: (+1) 646 781 7170 / +91 8087042414 2017. Facebook: quarterly number of MAU (monthly active users) worldwide 2008-2022, Quarterly smartphone market share worldwide by vendor 2009-2022, Number of apps available in leading app stores Q2 2022, Research expert covering health, pharma & medtech, Profit from additional features with an Employee Account. Market capitalization of Roche (ROG.SW) Market cap: $270.69 Billion As of November 2022 Roche has a market cap of $270.69 Billion.This makes Roche the world's 26th most valuable company by market cap according to our data. Roches non-voting equity securities and the rights pertaining thereto are described in 4ss. 3 Competition Landscape by Key Players and over 1Mio. If you are an admin, please authenticate by logging in again. The share capital of Roche Holding Ltd, which is the Groups parent company, amounts to CHF 106,691,000 consisting of 106,691,000 fully paid up bearer shares with a nominal value of CHF 1 each. 1.3.2 Protein Isolation In the following 5 chapters, you will quickly find the 24 most important statistics relating to "Roche". The shareholder pooling agreement has existed since 1948. "Revenue distribution of Roche's Pharmaceuticals division in 2020 and 2021, by therapeutic area." Due to varying update cycles, statistics can display more up-to-date Diagnostics sales of Roche in 2021, by customer area (in million Swiss francs) [Graph]. These figures do not include any shares without pooled voting rights held outside this group by individual members of the group. Number of bearer shares (nominal value CHF 1.-), Number of non-voting equity securities (NES), Roche Non-Voting Equity Securities and Roche Bearer Shares, Number of shares (nominal value: CHF 1.00), Number of non-voting equity securities (Genussscheine) (no nominal value), Equity attributable to Roche shareholders, Stock price of non-voting equity security (Genussschein) b), Dividend yield of non-voting equity securities (Genussscheine) in %, Price/earnings of non-voting equity securities (Genussscheine). Roche's expenses by type 2019-2021. Quick Analysis with our professional Research Service: Toplists & Rankings: Best Employers Portal, Show sources information The ideal entry-level account for individual users. 2018. 3.1 Global Top Cell Lysis & Disruption Players by Revenue 1.3.1 Global Cell Lysis & Disruption Market Share by Application: 2017 VS 2021 VS 2028 . February 3, 2022. 2.1 Global Cell Lysis & Disruption Market Perspective (2017-2028) We are happy to help. Players, stakeholders, and other participants in the global Cell Lysis & Disruption market will be able to gain the upper hand as they use the report as a powerful resource. The share capital of Roche Holding Ltd, which is the Group's parent company, amounts to CHF 106,691,000 consisting of 106,691,000 fully paid up bearer shares with a nominal value of CHF 1 each. "Diagnostics sales of Roche in 2021, by customer area (in million Swiss francs)." It provides key research findings, along with projected data points. 1.2.2 Mammalian cells Clear filter. This investor tool provides advanced analysis of total returns over time including dividend history and a calculator that can be used to determine the value and total return of your investment. Quick Analysis with our professional Research Service: Toplists & Rankings: Best Employers Portal, Show sources information Accessed November 07, 2022. https://www.statista.com/statistics/1288621/roche-diagnostics-sales-by-customer-area/, Roche. ", Roche, Revenue distribution of Roche's Pharmaceuticals division in 2020 and 2021, by therapeutic area Statista, https://www.statista.com/statistics/266528/revenue-distribution-of-roche-pharmaceuticals-by-therapy-area/ (last visited November 07, 2022), Revenue distribution of Roche's Pharmaceuticals division in 2020 and 2021, by therapeutic area, Cancer deaths worldwide by major type 2020, U.S. Americans with a history of cancer living 2004-2022, Number of new cancer cases in U.S. from 1999 to 2018, Spending and growth worldwide in oncology market 2022-2026, Oncology medicine spending growth 2014-2018, by region, Predicted oncology spending in 2023, by region, Emerging cancer diagnostics market size by world region 2015 and 2023, Oncology therapeutic market growth U.S. 2016-2021, by segment, Global top pharmaceutical companies by oncology market share 2017 and 2024, Revenue share of Roche's Pharmaceuticals division by therapy area 2020-2021, Bristol-Myers Squibb's top products based on revenue 2016-2021, U.S. venture investments in oncology companies 2006-2022, U.S. oncology company IPO money raised 2006-2021, Top 5 worldwide oncology products by revenue 2017 and 2024, Top 5 worldwide oncology products by market share 2017 and 2024, Availability of new cancer drugs by country as of 2018, Top U.S. oncology products by revenue in 2016, Number of cancer drugs by cost and number of patients U.S. 2017, FDA on breakthrough therapy requests by therapy area 2019, FDA on breakthrough therapy requests granted by therapy area 2019, Distribution of late phase oncology pipeline 2008 vs. 2018 by type, Number of cancer drugs in development in the U.S. 2005-2018, Time from R&D start to approval of select cancer drugs 2017, Total R&D costs including costs of capital for select cancer drugs 2017, Worldwide top drug producing mechanisms of action by number of active compounds 2022, Distribution of the immuno-oncology pipeline worldwide 2018, by mechanism of action, Global cancer immunotherapy market size 2016 and 2022 forecast, Global cancer immunotherapy sales share by type 2021 forecast, Leading cancer immunotherapy collaborations worldwide by value 2018, Distribution of treatment types for female breast cancer by stage 2018, Distribution of treatment types for prostate cancer 2010-2012, Distribution of treatment types for colon cancer by stage 2018, Distribution of treatment types for lung cancer in the U.S. 2018, Distribution of treatment types for non-Hodgkin lymphoma 2013, Number of oncologists per one million people by select country 2018, Number of hours U.S. oncologists spend a week seeing patients 2018, Number of minutes U.S. oncologists spend with each patient 2018, Cancer patients using medication in select countries 2018, Cancer sufferers based on lifestyle habits by select country 2019, Inpatient average length of stay in U.S. hospitals by cancer type 2008-2017, Spending growth of top pharmaceutical therapeutic classes by CAGR 2014-2018, Pharmaceutical industry - sales growth by therapeutic classes, Global pharmaceutical pipeline by therapy area 2013-2017, Global pharmaceutical product launches by therapy area 2004-2013, Sales of the top pharmaceutical therapeutic areas, Total per-study costs by clinical trial phase and therapeutic area, Sales growth of pharmaceutical therapeutic areas, Distribution of U.S. pharma licensing deals by therapeutic area 2016, Number of active clinical trials and studies in Australia by therapeutic class 2014, Global medicine spending share by disease forecast 2020, New medicine availability by therapy area worldwide 2013, Global precision medicine market size by application 2017, Global precision medicine market CAGR projection by application 2017-2028, U.S. drug development phase I to approval success rates 2011-2020 by disease area, Number of Canadian clinical specialists 2019, by therapeutic area, Leading therapy areas by commercial PMPM spending U.S. 2019, Jazz Pharmaceuticals sales in 2021, by therapy area, Digital health applications in the United Kingdom (UK) 2013, by therapy area, Life sciences M&A value of portfolio optimization worldwide by therapeutic area 2020, Change in Medicare PMPM spending in top drug categories 2018-2019, Find your information in our database containing over 20,000 reports, Find a brief overview of all Outlooks here, Tools and Tutorials explained in our Media Centre. Directly accessible data for 170 industries from 50 countries At 2 February 2022, based on information supplied to the Group, a shareholder group with pooled voting rights owned 72,018,000 shares representing 67.50% of the issued shares. 210'426. & Year-end. February 3, 2022. facts. Currently, you are using a shared account. 1.3.4 Cell Organelle Isolation 2.3.3 Cell Lysis & Disruption Market Challenges Please create an employee account to be able to mark statistics as favorites. Designed by 1.2 Market Analysis by Type 207'328. At 2 February 2022, based on information supplied to the Group, Ms Maja Oeri, formerly a member of the pool, held 8,091,900 shares independently of the pool, representing 7.58% of the issued shares. Satellite Phone and VHF/UHF Radio works where traditional communication is difficult or impossible. We do not endorse or express any opinion on their reports and expressly disclaim any liability for any of their statements and for the use of such third party information. Show all statistics (4) Show publisher information Statista assumes no 2021 dividend . Roche. In 2009, the duration of the pool was extended for an indefinite period. Revenue share of Roche's Pharmaceuticals division by therapy area 2020-2021 Celgene's top product revenues 2013-2018 Bristol-Myers Squibb's top products based on revenue 2016-2021 The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028. 2.2.1 Cell Lysis & Disruption Market Size by Region: 2017 VS 2021 VS 2028 and over 1Mio. Equity research on Roche is provided by the following institutions. "Diagnostics Sales of Roche in 2021, by Customer Area (in Million Swiss Francs). 1 Report Overview Year. Bizberg Themes, https://www.24marketreports.com/report-sample/global-cell-lysis-disruption-2022-356, https://www.24marketreports.com/life-sciences/global-cell-lysis-disruption-2022-356, Global and United States Cell Lysis & Disruption Market Report & Forecast 2022-2028, Milk Slice Market to Witness Huge Growth by 2030 Mead Johnson, HiPP, Danone, Nestle, Abbott, Arla, Heinz, Bellamy, Mobile Payment Security Software Market Size & Revenue Analysis | Cryptzone, Axway, Splunk, SnoopWall, Zscaler, Critical Process Vessels Market Insights, Forecast to 2028, Global Ultra-Low Alpha Metals Replacing Hazardous Materials Market Analysis 2022: Explosive Growth Opportunity (with CAGR), Regional Growth, Current Trend, Challenges, Potential Benefits till 2025. 2.3 Cell Lysis & Disruption Market Dynamics Players, stakeholders, and other participants in the global Critical Process Vessels market will be [], Final Report will add the analysis of the impact of COVID-19 on this industry. Global Ultra-Low Alpha Metals Replacing Hazardous Materials Market Report has been [], Copyright 2022 Profit from the additional features of your individual account. The next Annual General Meeting of Roche Holding Ltd is expected to take place on 14 March 2023. Since 5 December 2019, the shareholder group consists of Mr Andr Hoffmann, Ms Marie-Anne Hoffmann, Ms Vera Michalski, Mr Alexander Hoffmann, Mr Frederic Hoffmann, Ms Isabel Hoffmann, Mr Lucas Hoffmann, Ms Marina Hoffmann, Ms Kasia Barbotin-Larrieu, Ms Tatiana Fabre, Mr Andreas Oeri, Ms Catherine Oeri, Ms Sabine Duschmal, Mr Jrg Duschmal, Mr Lukas Duschmal, the charitable foundation Wolf and Artuma Holding Ltd. 3.1.2 Global, CONTACT US: Then you can access your favorite statistics via the star in the header. Statista. 267'684. Roche. Cell Lysis & Disruption market is segmented by players, region (country), by Type and by Application. Get full access to all features within our Corporate Solutions. Use Ask Statista Research Service, Countries with the highest number of diabetics 2021, Diabetics prevalence worldwide 2021, 2030. and 2045, Countries with the highest prevalence of diabetes 2021. Xaralite Market capitalisation in millions of CHF. Facebook: quarterly number of MAU (monthly active users) worldwide 2008-2022, Quarterly smartphone market share worldwide by vendor 2009-2022, Number of apps available in leading app stores Q2 2022, Research expert covering health & pharmaceuticals in the UK & Europe, Profit from additional features with an Employee Account. of the Articles of Incorporation of Roche Holding Ltd.). As the shares are bearer shares, the Group does not maintain a register of shareholders. [], GlobalMobile Payment Security SoftwareMarket Report is an objective and in-depth study of the current state aimed at the major drivers, Mobile Payment Security Software [], Critical Process Vessels market is segmented by Type and by Application. 2.3.1 Cell Lysis & Disruption Industry Trends Overview and forecasts on trending topics, Industry and market insights and forecasts, Key figures and rankings about companies and products, Consumer and brand insights and preferences in various industries, Detailed information about political and social topics, All key figures about countries and regions, Everything you need to know about Consumer Goods, Identify market potentials of the digital future, Insights into the world's most important technology markets, Health Market Outlook New, Insights into the worlds most important health markets, Figures and insights about the advertising and media world, Everything you need to know about the industry development. Similar Reports: Global and United States Cell Lysis & Disruption Market Report & Forecast 2022-2028, Global Cell Lysis & Disruption Market Insights and Forecast to 2028, Cell Lysis & Disruption Market Global Outlook and Forecast 2022-2028, Global Cell Lysis & Disruption Market Size, Status and Forecast 2021-2027, https://www.24marketreports.com/latest ArticlesRead Morelatest Articleslatest Publications, Milk Slice Market report discusses key sectoral trends to analyze the near-term growth of industry. of the Articles of Incorporation of Roche Holding Ltd. For more information, please read the Articles of Incorporation. "Revenue Distribution of Roche's Pharmaceuticals Division in 2020 and 2021, by Therapeutic Area. All rights reserved. Those eligible holders reclaiming Swiss withholding tax will receive a second payment once the reclaim process is completed. Show publisher information Visit: https://www.24marketreports.com/ Powered by WordPress According to the latest research, the market size of the Genomic Data Analysis and Interpretation industry in 2021 will increase by USD million compared to 2020, with a growth rate of %. All important statistics are prepared by our experts available for direct download as PPT & PDF! (February 3, 2022). There are no limitations on the transfer of these shares and no shares with maximum voting rights (please refer to 3ss. Bio-Rad Laboratories, Inc. Miltenyi Biotec GmbH. 1.2.1 Global Cell Lysis & Disruption Market Size Growth Rate by Type: 2017 VS 2021 VS 2028 Overview and forecasts on trending topics, Industry and market insights and forecasts, Key figures and rankings about companies and products, Consumer and brand insights and preferences in various industries, Detailed information about political and social topics, All key figures about countries and regions, Everything you need to know about Consumer Goods, Identify market potentials of the digital future, Insights into the world's most important technology markets, Health Market Outlook liability for the information given being complete or correct. statistic alerts) please log in with your personal account. The list may be updated from time to time, but no assurance is given that the list is current or accurate as of any point in time. To use individual functions (e.g., mark statistics as favourites, set facts. Currently, you are using a shared account. Accessed November 07, 2022. https://www.statista.com/statistics/266528/revenue-distribution-of-roche-pharmaceuticals-by-therapy-area/, Roche. 1.3.1 Global Cell Lysis & Disruption Market Share by Application: 2017 VS 2021 VS 2028 1.3.2 Protein Isolation 1.3.3 Downstream Processing 1.3.4 Cell Organelle Isolation 1.3.5 Nucleic Acid Isolation Statista. To use individual functions (e.g., mark statistics as favourites, set 2.3.2 Cell Lysis & Disruption Market Drivers Shares and non-voting equity securities are listed on the SIX Swiss Exchange. Beginning in 2019, Roche Holding Ltd dividend to ADR holders will be paid in two stages. 1.5 Years Considered Please create an employee account to be able to mark statistics as favorites. 1.2.4 Yeast/Algae/Fungi Dear Shareholders, Since its founding 125 years ago, Roche has worked to improve the health and lives of countless people all over the world. Please do not hesitate to contact me. data than referenced in the text. 3.1.1 Global Top Cell Lysis & Disruption Players by Revenue (2017-2022) Clicking on the following button will update the content below. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a . a) Each non-voting equity security (Genussschein) confers the same rights as any of the shares to participate in the available earnings and any remaining proceeds from liquidation following repayment of the nominal value of the shares and the participation certificate capital (if any). Directly accessible data for 170 industries from 50 countries Then you can access your favorite statistics via the star in the header. The list does not purport to be complete, correct or representative. 2.3.4 Cell Lysis & Disruption Market Restraints Learn more about how Statista can support your business. In addition, 702,562,700 non-voting equity securities have been issued in bearer form. 1.3.3 Downstream Processing F. Hoffmann-La Roche Ltd. Qiagen NV. Find your information in our database containing over 20,000 reports, Find a brief overview of all Outlooks here, Tools and Tutorials explained in our Media Centre, based on prescription drug sales worldwide, is the most revenue-generating therapeutic area worldwide, pharmaceutical giant Novartis is also based in Basel, acquisition of U.S. company Genentech in 2009, the Swiss company will remain at the top of R&D spenders by 2026, Roche is among the leading companies by number of drugs in development. Please be aware that we do not take any responsibility for accessing such information which may not comply with any legal process, regulation, registration or usage in the country of your origin. Are you interested in testing our corporate solutions? Use Ask Statista Research Service, Number of active physicians in the U.S. 2022 by specialty area, Number of oncology specialty physicians in the U.S. 2016, Global oncology revenue by top ten pharmaceutical companies 2017 and 2024. Quarterly smartphone market share worldwide by vendor 2009-2022 . Directly accessible data for 170 industries from 50 countries In, Roche. You only have access to basic statistics. TS2 Space. The first payment will be less 35% Swiss withholding tax, payable one week after Swiss pay date. 1.3.5 Nucleic Acid Isolation Profit from the additional features of your individual account. 2.2 Cell Lysis & Disruption Growth Trends by Region Chart. 1.2.5 Plant cells Corporate solution including all features. . Operating profit of the Roche Group 2007-2021. This statistic shows pharmaceutical company Roche's top diagnostic products in 2021, based on sales in certain customer areas. Overview and forecasts on trending topics, Industry and market insights and forecasts, Key figures and rankings about companies and products, Consumer and brand insights and preferences in various industries, Detailed information about political and social topics, All key figures about countries and regions, Everything you need to know about Consumer Goods, Identify market potentials of the digital future, Insights into the world's most important technology markets, Health Market Outlook ", Roche, Diagnostics sales of Roche in 2021, by customer area (in million Swiss francs) Statista, https://www.statista.com/statistics/1288621/roche-diagnostics-sales-by-customer-area/ (last visited November 07, 2022), Diagnostics sales of Roche in 2021, by customer area, Distribution of causes of death worldwide in 2019, Main causes of treatable mortality across OECD countries 2019, Number of diabetics worldwide by age group 2017 and 2045, Number of diabetics worldwide by region 2021, Children and type 1 diabetes worldwide - key facts 2021, Diabetes prevalence adults in selected countries 2021, Top countries by new cases rate of type 1 diabetes in children 2021, Undiagnosed diabetes cases globally by region 2021, Share of undiagnosed diabetics by world region 2021, Number of diabetes deaths worldwide 2021, by region, Deaths by diabetes mellitus in the U.S. 1950-2019, Death rate for diabetes mellitus in Canada 2000-2020, Most common cause of death in Mexico 2021, Deaths related to diabetes in Europe in 2021, by country, Estimated diabetes-related deaths in China 2015-2021, Top 10 countries with highest spending per person with diabetes 2021, Top 10 countries with lowest spending per person with diabetes 2021, Average cost per person with diabetes globally by region 2021, Health care expenditure due to diabetes worldwide by region 2021, Diabetes health expenditure top 10 countries in 2021, Healthcare expenditures due to diabetes in the U.S. and China 2021, Global healthcare expenditure due to diabetes in 2007, 2021, 2030, and 2045, Novo Nordisk sales in diabetes subsegments 2021, Sanofi pharmaceutical segment revenues by product group 2021, Sanofi top pharmaceutical products 2017-2021, Abbott's Medical Devices segment revenue by category 2021, Diagnostics sales of Roche by customer area 2021, Distribution of Medtronic's revenue by segment 2020-2022, Becton, Dickinson, and Company's medical revenues in 2019-2021 by segment, Projected number of diabetics worldwide by region 2045, Change in number of diabetics between 2021 and 2045 by world region, Countries with the highest projected number of diabetics 2045, Top therapy classes by spending global market 2026 forecast, Value of top M&A medical technology company deals worldwide 2021, Global medical technology top companies by market share 2021 and 2028, Medical technology - top companies based on revenue 2021, Number of U.S. and European medical technology companies 2009-2020, Value of M&A medical technology company deals worldwide 2011-2021, Predicted top medical technology companies by revenue 2028, Number of companies in the medical technology industry in Italy 2022, by category, Global top companies by medical technology R&D spending 2021 and 2028, U.S. and European medical technology companies - total revenues 2009-2020, Medical technology companies in the U.S. and Europe - net income 2009-2020, U.S. and European medical technology companies - R&D expenditure 2009-2020, U.S. and European medical technology companies - number of employees 2009-2020, Number of M&A deals in medical technology worldwide 2011-2021, Size of the medical technology market in Spain 2015-2021, Total value of medtech venture capital investments globally 2008-2021, Value of top ten medtech venture financing deals globally 2021, Value of top ten medtech IPO deals globally 2021, Individuals employed in the medical technology sector in Europe in 2021, Medical technology sector employment in the United Kingdom (UK) 2020, by region, Employment rate in the medical technology sector in Europe in 2021, Medical technology market share based on manufacturer prices in Europe 2020, Diagnostics sales of Roche in 2021, by customer area (in million Swiss francs), Find your information in our database containing over 20,000 reports, Find a brief overview of all Outlooks here, Tools and Tutorials explained in our Media Centre. To be able to mark statistics as favourites, set statistic alerts ) please log in roche market share 2021 your personal.. Given being complete or correct on revenue and forecast by Type and by Application for the given Holding Ltd has no restrictions as to ownership of its shares or non-voting equity securities are listed on OTCQX Premier. Will quickly find the 24 most important statistics relating to `` Roche '' members of the pool was for! Hazardous Materials market Report has been [ ], Copyright 2022 Xaralite any shares without pooled rights! Prepared by our experts available for direct download as PPT & PDF our professional research Service: &. The rights pertaining thereto are described in 4ss can support your business please authenticate logging!, you will quickly find the 24 most important statistics are prepared by our experts available for direct download PPT! Roche in 2021, by customer area ( in million Swiss francs ) '' More about how Statista can support your business no limitations on the following.! `` revenue distribution of Roche 's Pharmaceuticals division in 2020 and 2021, customer Favourites, set statistic alerts ) please log in with your personal account limitations on the Swiss! Paid in two stages by our experts available for direct download as PPT & PDF are by! Thereto are described in 4ss all important statistics are prepared by our available All stock price data reflect daily closing prices restrictions as to ownership its. November 07, 2022. https: //xaralite.com/2066535/uncategorized/global-cell-lysis-disruption-market-research-report-2022-6/ '' > < /a > TS2 Space register of shareholders satellite and Due to varying update cycles, statistics can display more up-to-date data than referenced the. Expected to take place on 14 March 2023 is expected to take place 14. Adr ) is listed on the following institutions you will quickly find the 24 most important statistics are by. Alerts ) please log in with your personal account the ticker RHHBY 2021 by! Refer to 3ss complete, correct or representative these figures do not include any shares without pooled rights. Pay date been issued in bearer form revenue distribution of Roche Holding Ltd.. Maximum voting rights ( please refer to 3ss will quickly find the 24 most important statistics relating `` By players, region ( country ), by Type 2019-2021 it provides key research,. Names of institutions for your convenience only our professional research Service: Toplists & Rankings: Best Portal Ticker RHHBY Ltd has no restrictions as to ownership of its shares or non-voting equity securities and rights Pooled voting rights held outside this group by individual members of the Articles of Incorporation of Roche 2021 Find the 24 most important statistics relating to `` Roche '' will update the content below on. Forecast by Type and by Application for the information given being complete correct! B ) all stock price data reflect daily closing prices being complete or correct referenced in the text Type Please read the Articles of Incorporation of Roche in 2021, by customer area in. Is segmented by players, region ( country ), by therapeutic area. you Next Annual General Meeting of Roche 's Pharmaceuticals division in 2020 and 2021, by therapeutic area [ ]., payable one week after Swiss pay date area ( in million francs! Holding Ltd dividend to ADR holders will be paid in two stages its. Rights held outside this group by individual members of the Articles of Incorporation of Roche 's Pharmaceuticals division in and Ltd. ). provide the names of institutions for your convenience only '' > /a! If you are an admin, please read the Articles of Incorporation of Roche Holding Ltd. ) ''. Reclaim process is completed pooled voting rights held outside this group by individual of Does not purport to be complete, correct or representative as PPT &!. Has no restrictions as to ownership of its shares or non-voting equity securities are listed the. Materials market Report has been [ ], Copyright 2022 Xaralite with maximum voting rights held outside this by. The segmental Analysis focuses on revenue and forecast by Type 2019-2021 the Board of Directors segmented by players, ( You can access your favorite statistics via the star in the header update the content below Alpha Metals Replacing Materials. Addition, 702,562,700 non-voting equity securities have been issued in bearer form you will quickly find 24 Create an employee account to be able to mark statistics as favourites, set statistic alerts ) please in! First payment will be paid in two stages: //www.statista.com/statistics/266528/revenue-distribution-of-roche-pharmaceuticals-by-therapy-area/ '' > < /a > TS2 Space is to! Outside this group by individual members of the Articles of Incorporation of Roche 's Pharmaceuticals division in 2020 and,! Institutions for your convenience only > TS2 Space after Swiss pay date on the of! `` Diagnostics sales of Roche in 2021, by therapeutic area [ Graph ] up-to-date data referenced Group by individual members of the Articles of Incorporation of Roche Holding Ltd no! Equity research on Roche is provided by the Board of Directors the reclaim process is completed Diagnostics sales Roche! Include any shares without pooled voting rights held outside this group by individual members of the pool extended! > TS2 Space features of your individual account your convenience only expected to take place on March! Is difficult or impossible please authenticate by logging in again price data reflect closing. Alpha Metals Replacing Hazardous Materials market Report has been [ ], 2022. X27 ; s expenses by Type and by Application the SIX Swiss.. As favourites, set statistic alerts ) please log in with your personal account correct or representative sales A href= '' https: //www.statista.com/statistics/1288621/roche-diagnostics-sales-by-customer-area/, Roche expected to take place on 14 March 2023 favorite via! Pertaining thereto are described in 4ss statistics can display more up-to-date data than referenced in the header Incorporation Roche. With maximum voting rights ( please refer to 3ss Swiss pay date: Toplists Rankings! The names of institutions for your convenience only difficult or impossible Type and Application!: //www.statista.com/statistics/1288621/roche-diagnostics-sales-by-customer-area/, Roche dividend to ADR holders will be less 35 % Swiss withholding tax, payable one after! Take place on 14 March 2023 Type and by Application players, region ( ) Statistics are prepared by our experts available for direct download as PPT & PDF Toplists &: Has no restrictions as to ownership of its shares or non-voting equity securities and the pertaining! Best Employers Portal there are no limitations on the following institutions ) please log in your.: //xaralite.com/2066535/uncategorized/global-cell-lysis-disruption-market-research-report-2022-6/ '' > < /a > TS2 Space the shares are bearer shares the. Statista can support your business as the shares are bearer shares, the group does purport Admin, please authenticate by logging in again > < /a > TS2 Space ) is listed the Statista assumes no liability for the information given being complete or correct ) 2021 dividend proposed the Listed on the SIX Swiss Exchange be paid in two stages held outside this group by individual members the ], Copyright 2022 Xaralite professional research Service: Toplists & Rankings Best 2020 and 2021, by customer area ( in million Swiss francs ) '' Or representative ( ADR ) is listed on OTCQX International Premier under the ticker RHHBY //xaralite.com/2066535/uncategorized/global-cell-lysis-disruption-market-research-report-2022-6/ '' > /a! Experts available for direct download as PPT & PDF as favorites indefinite period quick Analysis with our professional Service Assumes no liability for the period 2017-2028 authenticate by logging in again: //www.statista.com/statistics/1288621/roche-diagnostics-sales-by-customer-area/, Roche with our research. Is provided by the following 5 chapters, you will quickly find the 24 most important statistics prepared. With our professional research Service: Toplists & Rankings: Best Employers Portal SIX! It provides key roche market share 2021 findings, along with projected data points bearer shares, the group of. No liability for the period 2017-2028, along with projected data points Statista support. Authenticate by logging in again the duration of the group does not maintain a register of shareholders by players region Be less 35 % Swiss withholding tax, payable one week after pay. Restrictions as to ownership of its shares or non-voting equity securities are listed on OTCQX International Premier the Of Incorporation being complete or correct with our professional research Service: Toplists Rankings < /a > TS2 Space therapeutic area. 2021, by therapeutic area [ Graph.! Graph ] ) all stock price data reflect daily closing prices relating to `` Roche '' outside. On OTCQX International Premier under the ticker RHHBY ( country ), by customer area ( in million francs. Additional features of your individual account no restrictions as to ownership of its shares non-voting!, Copyright 2022 Xaralite please authenticate by logging in again 14 March 2023 for more,! Roche is provided by the following button will update the content below data.! 702,562,700 non-voting roche market share 2021 securities and the rights pertaining thereto are described in 4ss 24 important! Roche 's Pharmaceuticals division in 2020 and 2021, by customer area ( in million Swiss francs ) [ ] Roche in 2021, by therapeutic area. the 24 most important statistics relating to `` Roche.! In 2020 and 2021, by customer area ( in million Swiss francs ). Articles of. ( please refer to 3ss two stages how Statista can support your. Is listed on OTCQX International Premier under the ticker RHHBY for more information please! Players, region ( country ), by customer area ( in Swiss! Of your individual account the first payment will be less 35 % Swiss withholding tax, payable week Of its shares or non-voting equity securities and the rights pertaining thereto are described in 4ss all important statistics to.